Takano, Eiko http://orcid.org/0000-0003-2623-0405
,
Maltais, Mathieu http://orcid.org/0000-0001-5096-1019
Kondo, Izumi http://orcid.org/0000-0002-1675-7310
Rolland, Yves http://orcid.org/0000-0002-1157-0215
Funding for this research was provided by:
the Gérontopôle of Toulouse, the French Ministry of Health (PHRC 2008, 2009)
Pierre Fabre Research Institute
Exhonit Therapeutics SA
Avid Radiopharmaceuticals, Inc.
the University Hospital Center of Toulouse
the Association Monegasque pour la Recherche sur la maladie d’Alzheimer
the UMR 1027 Unit INSERM-University of Toulouse III
Article History
Received: 3 July 2020
Accepted: 17 February 2021
First Online: 5 March 2021
Compliance with ethical standards
:
: The authors report no conflicts of interest.
: The ethics committee in Toulouse (Comité de Protections des Personnes, Sud-Ouest et Outre-Mer II, CPP SOOM II) approved the study.
: Written, informed consent was obtained from all participants.
: The participants consented to publication.
: The data that support the findings of this study are available from the corresponding author upon reasonable request. The protocol is registered in a public-access clinical trial database (ExternalRef removed, Number: NCT01513252).